Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1651 to 1700 of 2555

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Coeliac diseaseQS134
Children's attachmentQS133
Single-incision short sling mesh insertion for stress urinary incontinence in womenHTG419
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Miniature lens system implantation for advanced age-related macular degenerationHTG418
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Secukinumab for treating active ankylosing spondylitisTA407
Pegaspargase for treating acute lymphoblastic leukaemiaTA408
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Talimogene laherparepvec for treating unresectable metastatic melanomaTA410
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Intravenous fluid therapy in children and young people in hospitalQS131
Multimorbidity: clinical assessment and managementNG56
Social care for older people with multiple long-term conditionsQS132
Harmful sexual behaviour among children and young peopleNG55
QuikRead go for C-reactive protein testing in primary careMIB78
FLEXISEQ for osteoarthritisMIB80
Alere Afinion CRP for C-reactive protein testing in primary careMIB81
Mental health problems in people with learning disabilities: prevention, assessment and managementNG54
ContraceptionQS129
Transition between inpatient mental health settings and community or care home settingsNG53
Stable angina: managementCG126
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Axxent electronic brachytherapy system for early stage breast cancerMIB76
OSNA for colon cancer stagingMIB77
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancerTA403
Degarelix for treating advanced hormone-dependent prostate cancerTA404
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Early years: promoting health and wellbeing in under 5sQS128
Palliative care for adults: strong opioids for pain reliefCG140
Motor neurone diseaseQS126
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillationHTG417
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blastsTA399
Nivolumab in combination with ipilimumab for treating advanced melanomaTA400
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA387
QTUG for assessing falls risk and frailtyMIB73
Stretta System for gastro-oesophageal reflux diseaseMIB74
Non-Hodgkin's lymphoma: diagnosis and managementNG52
Alair bronchial thermoplasty system for adults with severe difficult to control asthmaMIB71
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional proceduresCG64
Non-alcoholic fatty liver disease (NAFLD): assessment and managementNG49
Oral health for adults in care homesNG48
Cellvizio confocal endomicroscopy system for characterising pancreatic cystsMIB69

Results per page

  1. 10
  2. 25
  3. 50
  4. All